New contract award under RFP: BAA NIH-niaid-dmid-08-20

Ended Definitive Contract Awarded Last action

Contract number
HHSN272200800043C
Awardee
Awarding agency
Obligated
$21,072,782

Award facts

Opportunity
Contract value 69% obligated
$30,704,925.57 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 23 offers Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
South San Francisco, CA 94080, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 7 -$1,115,609
Other Administrative Action 6 $0
Other Administrative Action 5 · Other functions - novel aminoglycoside agents for treatment of antimicrobial resistant category a and b bacterial infections -$0
Other Administrative Action 4 $0
Funding Only Action 3 · I.1. And i.3. Clause added $5,160,457
Funding Only Action 2 · Novel aminoglycoside agents for treatment of antimicrobial resistant category a and b bacterial infections $5,697,418
Other Administrative Action 1 $0
Original award $11,330,516

About this award

This is a $30,704,925.57 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Achaogen, Inc., a for-profit organization. The contract was awarded on September 1, 2008, with a period of performance through August 27, 2016, and was not set aside for any specific business type.

The contract was awarded under a Broad Agency Announcement (BAA) solicitation, BAA NIH-NIAID-DMID-08-20, which suggests the contract involves research and development work related to infectious diseases for NIAID. While the specific products or services to be delivered are not detailed, the contract award indicates Achaogen is the prime contractor responsible for executing the work.

Quick answers

Who was awarded contract HHSN272200800043C?

HHSN272200800043C was awarded to Achaogen, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2008.

How much is contract HHSN272200800043C worth?

The government has obligated $21,072,782 on HHSN272200800043C. Its current value, with exercised options, is $30,704,926.

Was contract HHSN272200800043C competed?

The extent of competition for HHSN272200800043C was full and open competition. The government received 23 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award